Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
CoVigilAI is a cutting-edge solution for monitoring medical literature that leverages artificial intelligence and sophisticated data analysis to identify and manage adverse drug reactions proactively, thereby safeguarding patient well-being and adhering to regulatory standards in real time. This platform simplifies the tracking of scientific and medical literature by sourcing information from major global databases like PubMed and Embase, offering customizable search parameters that enhance the pharmacovigilance literature review process. Additionally, it systematically reviews scientific articles and publications from various local journals, ensuring comprehensive global and localized literature oversight. Utilizing advanced algorithms, the system classifies Individual Case Safety Reports (ICSRs) into three categories: valid, potential, and invalid cases, while its automated key entity recognition capability adeptly identifies essential elements such as patients, medications, adverse reactions, and relevant medical events. This holistic approach not only streamlines the monitoring process but also significantly enhances the accuracy and efficiency of drug safety assessments.
Description
Sci-Bot is an innovative research assistant powered by artificial intelligence, leveraging the resources of Sci-Hub to address user inquiries by directly exploring and analyzing scientific literature rather than relying on generalized training data. The system operates by meticulously scanning an extensive collection of full-text academic publications, extracting pertinent information to formulate responses that are firmly rooted in existing research, often providing citations and links to the original works. Users interact with Sci-Bot through an intuitive interface that accommodates multiple languages, as the system automatically identifies relevant keywords, retrieves scholarly articles, and organizes the information into coherent responses. Mirroring the methodology of a human researcher, it engages in a systematic approach that displays intermediate searches and sources prior to presenting a conclusive answer. By prioritizing the use of established scientific literature over generative outputs, Sci-Bot aims to minimize inaccuracies, while also facilitating direct access to complete documents, ensuring that users can verify and explore the original studies themselves. This approach not only enhances the reliability of the information provided but also encourages a deeper engagement with academic research.
API Access
Has API
API Access
Has API
Integrations
Embase
PubMed
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
Free
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
CoVigilAI
Country
India
Website
covigilai.in/
Vendor Details
Company Name
Sci-Bot
Country
United States
Website
sci-bot.ru/